MedPath

GOSHEN HEALTH SYSTEM

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

Phase 2
Conditions
Metastatic Cancer
Pancreatic Cancer
First Posted Date
2007-02-19
Last Posted Date
2013-12-19
Lead Sponsor
Goshen Health System
Target Recruit Count
20
Registration Number
NCT00436267
Locations
🇺🇸

Center for Cancer Care at Goshen General Hospital, Goshen, Indiana, United States

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

First Posted Date
2006-12-07
Last Posted Date
2013-12-19
Lead Sponsor
Goshen Health System
Target Recruit Count
20
Registration Number
NCT00408551
Locations
🇺🇸

Center for Cancer Care at Goshen General Hospital, Goshen, Indiana, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.